BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1934454)

  • 1. Eosinophilia-myalgia syndrome: the Cleveland Clinic experience.
    Thacker HL
    Cleve Clin J Med; 1991; 58(5):400-8. PubMed ID: 1934454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1992 Dec; 4(6):851-6. PubMed ID: 1457280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use.
    Varga J; Griffin R; Newman JH; Jimenez SA
    J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion.
    Beko E; Pervaiz S; Nanda V; Dhawan S
    Cutis; 1993 Apr; 51(4):266-70. PubMed ID: 8477608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous development of two cases of eosinophilia-myalgia syndrome with the same lot of L-tryptophan in Japan.
    Mizutani T; Mizutani H; Hashimoto K; Nakamura Y; Kishida M; Taniguchi H; Murata M; Kuzuhara S; Shimizu M
    J Am Acad Dermatol; 1991 Sep; 25(3):512-7. PubMed ID: 1918490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead.
    Sidransky H
    Mod Pathol; 1994 Sep; 7(7):806-10. PubMed ID: 7824518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A histopathologic comparison of Shulman's syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome.
    Feldman SR; Silver RM; Maize JC
    J Am Acad Dermatol; 1992 Jan; 26(1):95-100. PubMed ID: 1732344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic hepatitis: a new feature of the clinical spectrum of the eosinophilia-myalgia syndrome.
    Martinez-Osuna P; Espinoza CG; Cuellar ML; Cabrera GE; Silveira LH; Espinoza LR
    Clin Rheumatol; 1994 Sep; 13(3):528-32. PubMed ID: 7835024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eosinophilic fasciitis (Shulman syndrome). Differential diagnosis of chronic eosinophilia-myalgia syndrome after L-tryptophan administration].
    Schnabel A; Reusch M; Christophers E; Gross WL
    Internist (Berl); 1994 Jan; 35(1):63-6. PubMed ID: 8144322
    [No Abstract]   [Full Text] [Related]  

  • 12. [Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients].
    Mensing H; Schallreuter KU; Senff H; Steinkraus V
    Hautarzt; 1992 Jul; 43(7):436-40. PubMed ID: 1506202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis.
    Varga J; Jimenez SA; Uitto J
    J Invest Dermatol; 1993 Jan; 100(1):97S-105S. PubMed ID: 8423409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak.
    Hibbs JR; Mittleman B; Hill P; Medsger TA
    Arthritis Rheum; 1992 Mar; 35(3):299-303. PubMed ID: 1536667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cause and pathogenesis of the eosinophilia-myalgia syndrome.
    Varga J; Uitto J; Jimenez SA
    Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemia.
    Böhme A; Wolter M; Hoelzer D
    Ann Hematol; 1998 Nov; 77(5):235-8. PubMed ID: 9858150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of the eosinophilia-myalgia syndrome].
    Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
    Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
    Shapiro S
    J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [L-tryptophan-induced eosinophilia-myalgia syndrome with features of diffuse fasciitis with eosinophilia].
    Senff H; Köllner A; Engelmann L; Woort-Menker M; Mensing H; Kunze J
    Hautarzt; 1990 Oct; 41(10):578-82. PubMed ID: 2258302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan toxicity: a pharmacoepidemiologic review of eosinophilia-myalgia syndrome.
    Milburn DS; Myers CW
    DICP; 1991 Nov; 25(11):1259-62. PubMed ID: 1763543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.